Prevalence of Fractures in Postmenopausal Women with Thyroid Disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
We interviewed 300 white postmenopausal women (160 with thyroid disease, 140 without thyroid disease) to investigate whether having thyroid disease or taking thyroid hormone increased the prevalence of having a hip, vertebral, or forearm fracture. Thirty-seven (23%) women with thyroid disease and 45 (32%) women without thyroid disease had had a fracture, and there were no significant differences between these groups in the number or type of fractures. Dose of thyroid hormone and duration of therapy or disease did not affect fracture occurrence in women with thyroid disease. Women with a history of hyperthyroidism (9 of 32) or thyroid cancer (2 of 11) appeared to have their first fracture earlier (p < 0.01) than women without thyroid disease. In summary, women taking thyroid hormone for a variety of thyroid disorders do not appear to have an enhanced prevalence of a hip, vertebral, or forearm fractures, but women with a history of hyperthyroidism may have a propensity for their fractures to occur earlier in life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franklyn, J., Betteridge, J., Holder, R., Daykin, J., Lilley, J., & Sheppard, M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02572.x · Cited by 84
Cited by
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
“(506) interviewed 300 white postmenopausal women (160 with thyroid disease and 140 without thyroid disease) to investigate whether having thyroid disease or taking thyroid hormone increased the prevalence of having a hip, vertebral, or forearm fracture.”
BackgroundManagement of Simple Nodular Goiter: Current Status and Future Perspectives
Hegedüs, L., Bonnema, S. J., & Bennedbæk, F. N. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0016 · Cited by 710
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 363
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Self-citationThe Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S. L., & Greenspan, F. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00016 · Cited by 254
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156
“Solomon et al. (1993) found that postmenopausal women with a history of hyperthyroidism seemed to have a propensity for their fractures to occur earlier in life.”
BackgroundFerretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., & Beck-Peccoz, P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5553 · Cited by 134
Franklyn, J., Betteridge, J., Holder, R., Daykin, J., Lilley, J., & Sheppard, M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02572.x · Cited by 84
Hip fractures and the thyroid: a case‐control study
Wejda, B., Hintze, G., Katschinski, B., Olbricht, T., & Benker, G. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01172.x · Cited by 83
Jódar, E., Begoña López, M., García, L., Rigopoulou, D., Martínez, G., & Hawkins, F. (1998) · Osteoporosis International · doi:10.1007/s001980050069 · Cited by 59
Levothyroxine treatment and occurrence of fracture of the hip
Sheppard, M. C., Holder, R., & Franklyn, J. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.338 · Cited by 56
Hadji, P., Hars, O., Sturm, G., Bauer, T., Emons, G., & Schulz, K. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420445 · Cited by 28
“However, other studies have failed to confirm this decremental effect of L-T4 treatment on BMD (14‐17) or on the prevalence of fracture (18, 19 ).”
ResultEffects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Kim, E. H., Jeon, Y. K., Pak, K., Kim, I.-J., Kim, S.-J., Shin, S., Kim, B. H., Kim, S. S., Lee, B.-J., Lee, J.-G., et al. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.31 · Cited by 26
Ercolano, M. A., Drnovsek, M. L., Croome, M. C. S., Moos, M., Fuentes, A. M., Viale, F., Feldt-Rasmussen, U., & Gauna, A. T. (2013) · Thyroid Research · doi:10.1186/1756-6614-6-11 · Cited by 17
Papillary thyroid carcinoma is a risk factor for severe osteoporosis
Notsu, M., Yamauchi, M., Morita, M., Nawata, K., & Sugimoto, T. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01053-5 · Cited by 10
Penna, G. C., Bianco, A. C., & Ettleson, M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad629 · Cited by 8
Metadata
- Authors
- SOLOMON, B. L., WARTOFSKY, L., & BURMAN, K. D.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1993-01
- Volume
- 3
- Issue
- 1
- Pages
- 17-23
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2008796665
- Cited by
- 149
- References
- 1
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.